ARTICLE | Clinical News
Parsabiv regulatory update
December 21, 2016 1:01 AM UTC
Ono said Japan approved Parsabiv etelcalcetide to treat secondary hyperparathyroidism in patients on hemodialysis. Parsabiv is a peptide calcimimetic that acts on the parathyroid gland to reduce produ...
BCIQ Target Profiles